Evidence Hub

Comparative efficacy and safety of cabazitaxel versus other taxanes: a systematic review and meta-analysis

Salah Ameen Abdu, Cai-Yun He, Wafa Ali Asaad, M. Tufail, Ya Liao, Sadam Ahmed Elayah, Rao Zhen, Siying Chen et al.

Systematic Reviews, 2025

3,377 participants · 2 citations

Abstract

This systematic review addresses uncertainty around cabazitaxel's effectiveness, safety, and optimal dosing compared to other taxanes, aiming to guide personalized treatment and improve patient outcomes. A meta-analysis of randomized controlled trials (RCTs) assessed the efficacy and safety of cabazitaxel, including tumor response, survival rates, and toxicity profiles. Trials were identified from several databases, and the bias was evaluated by using the Cochrane RoB 2 tool. Review Manager (RevMan 5.4) was used for heterogeneity testing, sensitivity analyses, pooling hazard ratio (HR) and risk ratios (RR) with 95% confidence intervals (CI), and publication bias assessment. This meta-analysis included 10 trials with 3,377 patients. Cabazitaxel demonstrated no significant overall survival (OS) (HR = 1.03, 95% CI 0.92–1.14) or progression-free survival (PFS) (HR 1.07, 95% CI 0.92–1.24) benefit over other taxanes but had higher grade 3–5 treatment-related adverse events (TEAEs) (RR = 1.68, 95% CI 1.16–2.42). Tumor responses showed slightly higher partial responses (RR = 1.19, 95% CI 0.97–1.45) and increased progressive disease response (PDR) (RR = 1.60, 95% CI 1.15–2.23), with nonsignificant complete responses and stable disease. Subgroup analyses revealed no significant difference in OS or PFS for prostate and breast cancer. However, in head and neck cancer, cabazitaxel was associated with worse outcomes. 20 mg/m2 dose had a better safety profile, while 25 mg/m2 increased…

How strong is the evidence?

Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 3,377 participants or records.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free